The Relationship Between Antitumor Effects and Relative Dose Intensity of S-1 plus Cisplatin Treatment for Metastatic Gastric Cancer
Anticancer Research, 05/17/2012
Clinical Article
KITAGAWA M et al. – An appropriate RDI reduction may be permitted for patients with metastatic gastric cancer (MGC) in palliative settings.



